Carson Allaria Wealth Management, Ltd. Crispr Therapeutics Ag Transaction History
Carson Allaria Wealth Management, Ltd.
- $169 Million
- Q3 2024
A detailed history of Carson Allaria Wealth Management, Ltd. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Carson Allaria Wealth Management, Ltd. holds 368 shares of CRSP stock, worth $14,915. This represents 0.01% of its overall portfolio holdings.
Number of Shares
368
Previous 436
15.6%
Holding current value
$14,915
Previous $23,000
26.09%
% of portfolio
0.01%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding CRSP
# of Institutions
489Shares Held
57.9MCall Options Held
1.09MPut Options Held
1.9M-
Capital International Investors Los Angeles, CA7.93MShares$321 Million0.07% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.5MShares$304 Million3.35% of portfolio
-
State Street Corp Boston, MA2.99MShares$121 Million0.01% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.97MShares$120 Million0.1% of portfolio
-
Nikko Asset Management Americas, Inc.2.97MShares$120 Million1.61% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.16B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....